Natural bis-benzylisoquinoline alkaloids-tetrandrine, fangchinoline, and cepharanthine, inhibit human coronavirus OC43 infection of MRC-5 human lung cells DE Kim, JS Min, MS Jang, JY Lee, YS Shin, CM Park, JH Song, HR Kim, ... Biomolecules 9 (11), 696, 2019 | 302 | 2019 |
Bilirubin nanoparticles ameliorate allergic lung inflammation in a mouse model of asthma DE Kim, Y Lee, MG Kim, S Lee, S Jon, SH Lee Biomaterials 140, 37-44, 2017 | 115 | 2017 |
Leukotrienes in tumor-associated inflammation W Tian, X Jiang, D Kim, T Guan, MR Nicolls, SG Rockson Frontiers in pharmacology 11, 1289, 2020 | 65 | 2020 |
Prediction of drug-induced immune-mediated hepatotoxicity using hepatocyte-like cells derived from human embryonic stem cells DE Kim, MJ Jang, YR Kim, JY Lee, EB Cho, E Kim, Y Kim, MY Kim, ... Toxicology 387, 1-9, 2017 | 40 | 2017 |
Bilirubin nanomedicine ameliorates the progression of experimental autoimmune encephalomyelitis by modulating dendritic cells TW Kim, Y Kim, W Jung, DE Kim, H Keum, Y Son, S Jon Journal of Controlled Release 331, 74-84, 2021 | 39 | 2021 |
The role of regulatory T cells in pulmonary arterial hypertension W Tian, SY Jiang, X Jiang, R Tamosiuniene, D Kim, T Guan, S Arsalane, ... Frontiers in Immunology 12, 684657, 2021 | 35 | 2021 |
IL4 Receptor–targeted proapoptotic peptide blocks tumor growth and metastasis by enhancing antitumor immunity SMP Vadevoo, JE Kim, GR Gunassekaran, HK Jung, L Chi, DE Kim, ... Molecular Cancer Therapeutics 16 (12), 2803-2816, 2017 | 34 | 2017 |
Kurarinone inhibits HCoV-OC43 infection by impairing the virus-induced autophagic flux in MRC-5 human lung cells JS Min, DE Kim, YH Jin, S Kwon Journal of clinical medicine 9 (7), 2230, 2020 | 30 | 2020 |
Decreased lymphatic HIF-2α accentuates lymphatic remodeling in lymphedema X Jiang, W Tian, EJ Granucci, AB Tu, D Kim, P Dahms, S Pasupneti, ... The Journal of Clinical Investigation 130 (10), 5562-5575, 2020 | 25 | 2020 |
Exploring disease interrelationships in patients with lymphatic disorders: A single center retrospective experience SG Rockson, X Zhou, L Zhao, DK Hosseini, X Jiang, AJ Sweatt, D Kim, ... Clinical and translational medicine 12 (4), e760, 2022 | 15 | 2022 |
Bavachin produces immunoadjuvant activity by targeting the NFAT signaling pathway YH Jin, DE Kim, MS Jang, JS Min, S Kwon Phytomedicine 93, 153796, 2021 | 13 | 2021 |
Lymph node fibroblastic reticular cells regulate differentiation and function of CD4 T cells via CD25 D Kim, M Kim, TW Kim, Y Choe, HS Noh, HM Jeon, HS Kim, Y Lee, G Hur, ... Journal of Experimental Medicine 219 (5), e20200795, 2022 | 11 | 2022 |
Synthesis and biological evaluation of 3-acyl-2-phenylamino-1, 4-dihydroquinolin-4 (1H)-one derivatives as potential MERS-CoV inhibitors JH Yoon, JY Lee, J Lee, YS Shin, S Jeon, DE Kim, JS Min, JH Song, ... Bioorganic & Medicinal Chemistry Letters 29 (23), 126727, 2019 | 11 | 2019 |
Effects of 18β‐Glycyrrhetinic Acid on Fungal Protease‐Induced Airway Inflammatory Responses YH Kim, DE Kim, SH Lee Mediators of Inflammation 2018 (1), 6461032, 2018 | 11 | 2018 |
Hypoxia and hypoxia-inducible factors in lymphedema X Jiang, W Tian, D Kim, AS McQuiston, R Vinh, SG Rockson, ... Frontiers in Pharmacology 13, 851057, 2022 | 10 | 2022 |
Study on the 2‐Phenylchroman‐4‐One Derivatives and their anti‐MERS‐CoV Activities JH Yoon, J Lee, JY Lee, YS Shin, DE Kim, JS Min, CM Park, JH Song, ... Bulletin of the Korean Chemical Society 40 (9), 906, 2019 | 8 | 2019 |
Abnormal lymphatic sphingosine-1-phosphate signaling aggravates lymphatic dysfunction and tissue inflammation D Kim, W Tian, TTH Wu, M Xiang, R Vinh, JL Chang, S Gu, S Lee, Y Zhu, ... Circulation 148 (16), 1231-1249, 2023 | 5 | 2023 |
Protease allergen‐induced HMGB1 contributes to NLRC4 inflammasome‐mediated inflammation in experimental asthma. YH Kim, JO Lim, JS Kim, BY Kim, BJ Pyun, SJ Lee, DE Kim, SH Lee, ... Allergy 78 (5), 2023 | 5 | 2023 |
Rat microbial biogeography and age-dependent lactic acid bacteria in healthy lungs L Zhao, CM Cunningham, AM Andruska, K Schimmel, MK Ali, D Kim, S Gu, ... Lab Animal 53 (2), 43-55, 2024 | 1 | 2024 |